Shortening fraction of >= % by echocardiogram OR ejection fraction of >= % by multi-gated acquisition (MUGA)
Cardiac ejection fraction >= % (for HER+ patients) as assessed by echocardiogram, multi gated acquisition scan (MUGA) scan, or cardiac magnetic resonance imaging (MRI)
Patients with a cardiac ejection fraction (as measured by either Multi Gated Acquisition [MUGA] or echocardiogram [EKG]) < %
Baseline ejection fraction ? % as assessed by echocardiogram or multi-gated acquisition (MUGA) scan.
Ejection fraction < % obtained by either multi gated acquisition scan (MUGA) or echocardiogram
Normal cardiac ejection fraction (> %) by multi gated acquisition scan (MUGA) or echocardiogram
Adequate cardiac function defined as an ejection fraction of >= % by multi gated acquisition scan (MUGA) scan or echocardiogram and a corrected QT (QTc) interval of =<  ms for men and =<  ms for women
Patients with a cardiac ejection fraction (as measured by either multi-gated acquisition [MUGA] or echocardiogram) < %
A cardiac evaluation with an electrocardiogram showing no ischemic changes or abnormal rhythm and an ejection fraction of >= % established by multi-gated acquisition scan (MUGA) or echocardiogram
Ejection fraction of >= % by echocardiogram or multi-gated acquisition (MUGA) scan
A cardiac evaluation with an electrocardiogram showing no ischemic changes or abnormal rhythm and an ejection fraction of % established by multi-gated acquisition scan (MUGA) or echocardiogram
Ejection fraction > % by either multi-gated acquisition scan (MUGA) scan or echocardiogram
Ejection fraction (EF) >= % on multi gated acquisition (MUGA) scan or echocardiogram
Patients with a cardiac ejection fraction (as measured by either multi-gated acquisition [MUGA] scan or echocardiogram) < %; (Note: patients who have had prior anthracycline exposure of >  mg/m^ may be eligible after discussion with the principal investigator [PI])
For children with neuroblastoma (NBL): normal ejection fraction (> %) documented by echocardiogram or radionuclide multi-gated acquisition (MUGA) evaluation OR normal fractional shortening (> %) documented by echocardiogram; for subjects with paraganglioma/ pheochromocytoma: no clinically significant cardiac dysfunction
Cardiac ejection fraction of >= % by echocardiogram or multi gated acquisition scan (MUGA)
Ejection fraction measured by echocardiogram or multi gated acquisition scan (MUGA) > % (evaluation within  weeks of screening does not need to be repeated)
Normal cardiac function as defined by a normal ejection fraction by multi gated acquisition scan (MUGA) or echocardiogram
Cardiac ejection fraction of >= % by echocardiogram or multi gated acquisition scan (MUGA)
Cardiac ejection fraction >= % by multiple gate acquisition (MUGA) scan and/or by echocardiogram
Cardiac dysfunction documented by an ejection fraction less than the lower limit of the facility normal by multi-gated acquisition (MUGA) scan, or less than % by echocardiogram
Shortening fraction > % by echocardiogram or ejection fraction above the institutional lower limit of normal by multi gated acquisition scan (MUGA)
Multi gated acquisition scan (MUGA) > % injection fraction
Cardiac function:\r\n* Normal ejection fraction (>= %) documented by either echocardiogram or radionuclide multi gated acquisition scan (MUGA) evaluation; OR \r\n* Normal fractional shortening (>= %) documented by echocardiogram
Echocardiogram or multi gated acquisition (MUGA) scan demonstrating an ejection fraction >= %
Ejection fraction measured by echocardiogram or multi gated acquisition scan (MUGA) > %
Adequate cardiac function as defined by either of the following:            \r\n* An echocardiogram demonstrating an ejection fraction within normal limits\r\n* A multi gated acquisition (MUGA) scan demonstrating an ejection fraction within normal limits
Patients must have a cardiac ejection fraction > % on two-dimensional (D) echocardiography or multi gated acquisition scan (MUGA) obtained within  days of study enrollment
Has a shortening fraction of >% or an ejection fraction of ?% by echocardiogram or multi-gated acquisition scan
Subjects with multi gated acquisition scan (MUGA) < % ejection fraction (EF)
Ejection fraction >= % by radionuclide angiogram (multi gated acquisition scan [MUGA]); Note: the echocardiogram (or MUGA) may be done within  days prior to enrollment
Baseline ejection fraction >= % by multi gated acquisition scan (MUGA) scan or echocardiogram performed =<  days prior to registration
Intraventricular septal (IVS) thickness =<  mm (as determined by -dimensional [D] echocardiography or cardiac magnetic resonance imaging [MRI]) (ejection fraction may also be assessed by a multi-gated acquisition [MUGA])
Cardiac ejection fraction >= % by echocardiography (transthoracic echocardiography) or multi gated acquisition scan (MUGA) scan
Patients must have a multi gated acquisition scan (MUGA) or echocardiogram within  days prior to starting treatment and the ejection fraction must be >= %
Ejection fraction < %, as determined by echocardiogram or multi gated acquisition scan (MUGA)
Cardiac ejection fraction >= % as measured by echocardiogram of multiple gated acquisition scan (MUGA) scan
Ejection fraction (EF) > % by multi gated acquisition scan (MUGA)
Cardiac ejection fraction >= % by multi-gated acquisition (MUGA) scan and/or by echocardiogram
Patients with a cardiac ejection fraction (as measured by either multi gated acquisition scan [MUGA] or echocardiogram) less than %
Ejection fraction by multi gated acquisition scan (MUGA) scan or echocardiogram >= lower limit of institutional normal
Patients with prior anthracycline exposure must have a baseline multi gated acquisition scan (MUGA) or echocardiogram prior to study entry
Normal cardiac function (ejection fraction >= lower limit of normal) as determined by multi-gated acquisition scan (MUGA) or echocardiogram
Echocardiogram or multi gated acquisition (MUGA) scan with ejection fraction within normal institution limits within  days of registration
Meeting institutional criteria for allo-HCT; ejection fraction by echocardiogram or multi-gated acquisition scan (MUGA) > %, pulmonary function test with adjusted diffusion capacity of the lung for carbon monoxide (DLCO) >= %
Ejection fraction measured by echocardiogram or multi gated acquisition scan (MUGA) > %
A cardiac evaluation with an electrocardiogram showing no ischemic changes or abnormal rhythm and an ejection fraction of % established by multi gated acquisition scan (MUGA) or echocardiogram
Subjects with major cardiac illness multi-gated acquisition scan (MUGA) < % ejection fraction (EF)
Estimated cardiac ejection fraction >= % by echocardiogram or multi gated acquisition scan (MUGA)
